Should CVS Health Break Up?
CVS Health is reportedly exploring a breakup. But some experts aren’t sure if this is a good idea. The post Should CVS Health Break Up? appeared first on MedCity News.
Read More
What Is Needed to Rebuild Trust in U.S. Healthcare?
Americans largely trust their doctors but are skeptical of payers, drugmakers and hospital leadership — a divide fueled by rising costs and a complex, opaque healthcare system. Kristin Wikelius of United States of Care said restoring confidence will require more transparency, simpler navigation and policies that prioritize preventive care. The post What Is Needed to…
An Arm and a Leg: The Prescription Drug Playbook, Part II
In response to the high price of prescription drugs, “An Arm and a Leg” asked listeners to share their strategies for getting the medicine they need at prices they can manage. Host Dan Weissmann and producers Emily Pisacreta and Claire Davenport share tips from a retired hospital manager who now helps seniors find the right…
Kennedy v. Braidwood: The Supreme Court Upheld ACA Preventive Services but That’s Not the End of the Story
On June 27, 2025, the U.S. Supreme Court issued its opinion on Kennedy v. Braidwood Management, ruling that the ACA requirement that most private insurers and Medicaid expansion programs to cover preventive services recommended by the United States Preventive Services Preventive Task Force (USPSTF) with no cost-sharing is constitutional.
Kennedy Sharpens Vaccine Attacks, Without Scientific Backing
As the federal government prepares for the next meeting of its Advisory Committee on Immunization Practices, Health and Human Services Secretary Robert F. Kennedy Jr. has intensified his attacks on aluminum vaccine components used in many shots to boost the body’s immune response. Kennedy, a longtime anti-vaccine activist before seeking public office, claims that aluminum…
Stop Presenting at Health-Tech Buyers — Let Them Drive
Winning in health-tech is about giving buyers enough operational clarity, early enough, that they can say yes with confidence rather than saying yes because the alternative is another six months of the same evaluation cycle. The post Stop Presenting at Health-Tech Buyers — Let Them Drive appeared first on MedCity News.
She Struggled To Get a Lifesaving Drug Even After Insurers Vowed To Help
LADUE, Mo. — Over four consecutive days in January, Margaret Hvatum ran a 5K, a 10K, a half-marathon, and a full marathon. The 70-year-old covered a combined distance that’s nearly equivalent to running the length of Manhattan four times. By the end of the month, she was in a hospital bed. Hvatum, a part-time computer…
Choosing the Right Methods for the Right AI to Accelerate Prior Authorizations
With regulatory scrutiny intensifying and the demand for speed, compliance, and clarity growing, understanding the nuanced differences between AI approaches is essential for payers, providers, and patients alike. The post Choosing the Right Methods for the Right AI to Accelerate Prior Authorizations appeared first on MedCity News.
Why patient eligibility verification matters
Patient eligibility verification is a critical part of the healthcare revenue cycle. It can help prevent errors with claim submissions, reduce denials, boost the bottom line, and help patients understand what their insurance will cover. However, checking insurance eligibility isn’t always efficient or accurate, thanks to outdated systems and complicated manual processes. Ever-evolving payer requirements…
Nuvig Therapeutics Nabs $161M to Build Case for a Better Approach to Autoimmune Disease
The startup’s first disease target is chronic inflammatory demyelinating polyneuropathy (CIDP), which can be treated with a blockbuster Argenx drug. Nuvig aims to show its drug can offer a better way to treat this disease and other autoimmune conditions. The post Nuvig Therapeutics Nabs $161M to Build Case for a Better Approach to Autoimmune Disease…